Home › Forums › Infexion Connexion › CJD policies
- This topic has 0 replies, 2 voices, and was last updated 7 years, 9 months ago by Roel Castillo.
-
AuthorPosts
-
01/02/2017 at 1:03 pm #73593John FergusonParticipant
Author:
John FergusonEmail:
John.Ferguson@HNEHEALTH.NSW.GOV.AUOrganisation:
State:
Dear all,
Wed be grateful to look at your current policies as ours is well out of date (am aware of the national document) .
In common with many, many of our CSDs have adopted enzyme agents that are prion active and validated to reduce same by required proportion which adds a layer of safety. Im interested to learn to what extent others have been able to wind back parallel systems for sterilisation by having a mainstream approach that is of proven effectiveness against prions?
Thanks
JohnDr John Ferguson MBBS DTM&H FRACP FRCPA
Microbiologist | Pathology North, NSW Pathology
Infectious Diseases Physician | Immunology and Infectious Diseases Unit
Conjoint Assoc. Professor | University of Newcastle
John Hunter Hospital, Locked Bag 1, Newcastle Mail Centre, NSW 2310, Australia
T: 61 2 49214444 | F: 61 2 49214440 | M: +61(0)428 885573 (Speed Dial 67607) | Tw @mdjkfFollow http://www.aimed.net.au, the HNE Health/Pathology North site for practical discussions about antibiotic use.
Follow http://www.idmicnepal.net for microbiology and infectious diseases post graduate resources and discussions.
Follow http://www.biochemcase.wordpress.com for moderated case discussions from a renowned clinical biochemistry expert.[cid:image001.jpg@01D27C8B.A475AF00]
Unless explicitly attributed, the opinions expressed in this email are those of the author only and do not represent the official view of Hunter New England Local Health District nor the New South Wales Government.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
You can unsubscribe from this list be sending ‘signoff aicalist’ (wi
03/02/2017 at 12:24 pm #73594Hi
Please email me, I will send workflow/policy/procedure.
Also too MUH SSU has started 2D marking of NEURO/OPHTHALMIC and ENT instruments which is useful if we need to do a look back.
These might be of interest to read.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748700/
https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/div-classtitleguideline-for-disinfection-and-sterilization-of-prion-contaminated-medical-instrumentsdiv/2546FE55471E220B294E5B5C9EEE421ERoel Castillo
Sterilising Services Unit Manager
Macquarie University Hospital
3 Technology Place
Macquarie University, NSW 2109, Australia
Locked Bag 2231, North Ryde BC, NSW 1670T: +61 2 9812 3213 I M: +61 0 434 496 829
Email: roel.castillo@muh.org.au
http://www.muh.org.au[cid:image001.jpg@01D27E16.FD9FE320]
Macquarie University Hospital is Australias first and only private hospital on a University campus. We are committed to delivering superior clinical outcomes and a positive patient experience through the best available care and technology.
Disclaimer: This message is intended for the addressee named and may contain confidential information. If you are not the intended recipient, please delete it and notify the sender. Views expressed in this message are those of the individual sender, and are not necessarily the views of Macquarie University Hospital.**********************************************************************
This message is intended for the addressee named and may contain
privileged information or confidential information or both. If you
are not the intended recipient please delete it and notify the sender.
**********************************************************************From: ACIPC Infexion Connexion [mailto:AICALIST@AICALIST.ORG.AU] On Behalf Of John Ferguson
Sent: Wednesday, 1 February 2017 1:04 PM
To: AICALIST@AICALIST.ORG.AU
Subject: CJD policiesDear all,
Wed be grateful to look at your current policies as ours is well out of date (am aware of the national document) .
In common with many, many of our CSDs have adopted enzyme agents that are prion active and validated to reduce same by required proportion which adds a layer of safety. Im interested to learn to what extent others have been able to wind back parallel systems for sterilisation by having a mainstream approach that is of proven effectiveness against prions?
Thanks
JohnDr John Ferguson MBBS DTM&H FRACP FRCPA
Microbiologist | Pathology North, NSW Pathology
Infectious Diseases Physician | Immunology and Infectious Diseases Unit
Conjoint Assoc. Professor | University of Newcastle
John Hunter Hospital, Locked Bag 1, Newcastle Mail Centre, NSW 2310, Australia
T: 61 2 49214444 | F: 61 2 49214440 | M: +61(0)428 885573 (Speed Dial 67607) | Tw @mdjkfFollow http://www.aimed.net.au, the HNE Health/Pathology North site for practical discussions about antibiotic use.
Follow http://www.idmicnepal.net for microbiology and infectious diseases post graduate resources and discussions.
Follow http://www.biochemcase.wordpress.com for moderated case discussions from a renowned clinical biochemistry expert.[http://www.health.nsw.gov.au/images/communications/e-signatures/images/NSW-Health-Master.jpg]
Unless explicitly attributed, the opinions expressed in this email are those of the author only and do not represent the official view of Hunter New England Local Health District nor the New South Wales Government.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
You can unsubscribe from this list be sending ‘signoff aical
-
AuthorPosts
- The forum ‘Infexion Connexion’ is closed to new topics and replies.